U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

3-hydroxyisovaleric aciduria

MedGen UID:
1746334
Concept ID:
C5421619
Finding
Synonym: Increased urine 3-hydroxyisovaleric acid level
 
HPO: HP:0033111

Definition

Concentration of 3-hydroxyisovaleric acid in the urine above the normal range. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGV3-hydroxyisovaleric aciduria

Conditions with this feature

Holocarboxylase synthetase deficiency
MedGen UID:
120653
Concept ID:
C0268581
Disease or Syndrome
Holocarboxylase synthetase deficiency, a biotin-responsive multiple carboxylase deficiency (MCD), is characterized by metabolic acidosis, lethargy, hypotonia, convulsions, and dermatitis. Most patients present in the newborn or early infantile period, but some become symptomatic in the later infantile period (summary by Suzuki et al., 2005). Also see biotinidase deficiency (253260), another form of MCD with a later onset. Care must be taken to differentiate the inherited multiple carboxylase deficiencies from acquired biotin deficiencies, such as those that develop after excessive dietary intake of avidin, an egg-white glycoprotein that binds specifically and essentially irreversibly to biotin (Sweetman et al., 1981) or prolonged parenteral alimentation without supplemental biotin (Mock et al., 1981).
3-methylcrotonyl-CoA carboxylase 1 deficiency
MedGen UID:
78691
Concept ID:
C0268600
Disease or Syndrome
3-Methylcrotonylglycinuria is an autosomal recessive disorder of leucine catabolism. The clinical phenotype is highly variable, ranging from neonatal onset with severe neurologic involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency. MCC activity in extracts of cultured fibroblasts of patients is usually less than 2% of control (summary by Baumgartner et al., 2001). Also see 3-methylcrotonylglycinuria II (MCC2D; 210210), caused by mutation in the beta subunit of 3-methylcrotonyl-CoA carboxylase (MCCC2; 609014).
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
MedGen UID:
816734
Concept ID:
C3810404
Disease or Syndrome
Most children with carbonic anhydrase VA (CA-VA) deficiency reported to date have presented between day 2 of life and early childhood (up to age 20 months) with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Given that fewer than 20 affected individuals have been reported to date, the ranges of initial presentations and long-term prognoses are not completely understood. As of 2021 the oldest known affected individual is an adolescent. Almost all affected individuals reported to date have shown normal psychomotor development and no further episodes of metabolic crisis; however, a few have shown mild learning difficulties or delayed motor skills.

Recent clinical studies

Etiology

Ribeiro CA, Hickmann FH, Wajner M
Int J Dev Neurosci 2011 Feb;29(1):1-7. Epub 2010 Nov 2 doi: 10.1016/j.ijdevneu.2010.10.007. PMID: 21050883
Friebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P, Heubner G, Baumgartner MR, Hoffmann GF
Neuropediatrics 2006 Apr;37(2):72-8. doi: 10.1055/s-2006-924024. PMID: 16773504
Illsinger S, Lücke T, Zschocke J, Gibson KM, Das AM
Pediatr Neurol 2004 Mar;30(3):213-5. doi: 10.1016/j.pediatrneurol.2003.09.016. PMID: 15033206
Jones MG, Chalmers RA
Clin Chim Acta 2000 Oct;300(1-2):203-12. doi: 10.1016/s0009-8981(00)00324-7. PMID: 10958876
Mock DM, Mock NI, Nelson RP, Lombard KA
J Pediatr Gastroenterol Nutr 1998 Mar;26(3):245-50. doi: 10.1097/00005176-199803000-00002. PMID: 9523856

Diagnosis

Nardecchia F, Caciotti A, Giovanniello T, De Leo S, Ferri L, Galosi S, Santagata S, Torres B, Bernardini L, Carducci C, Morrone A, Leuzzi V
Int J Mol Sci 2022 Apr 16;23(8) doi: 10.3390/ijms23084422. PMID: 35457240Free PMC Article
Tal G, Dar DE, Idin A, Korman SH, Dumin E
Clin Chem 2018 Jun;64(6):978-980. doi: 10.1373/clinchem.2018.286617. PMID: 29844061
Tavasoli AR, Shervin Badv R, Zschocke J, Ashrafi MR, Rostami P
Brain Dev 2017 Sep;39(8):714-716. Epub 2017 Apr 21 doi: 10.1016/j.braindev.2017.04.007. PMID: 28438368
Bartlett K, Ng H, Leonard JV
Clin Chim Acta 1980 Jan 15;100(2):183-6. doi: 10.1016/0009-8981(80)90081-9. PMID: 6766095
Lehnert W, Niederhoff H, Junker A, Saule H, Frasch W
Eur J Pediatr 1979 Oct;132(2):107-14. doi: 10.1007/BF00447377. PMID: 499258

Therapy

Liu S, Zhang Y, Deng Z, He H, Zheng X, Hong Q, Luo X
Int J Mol Sci 2023 Jun 16;24(12) doi: 10.3390/ijms241210239. PMID: 37373384Free PMC Article
Fujimoto W, Inaoki M, Fukui T, Inoue Y, Kuhara T
J Dermatol 2005 Apr;32(4):256-61. doi: 10.1111/j.1346-8138.2005.tb00758.x. PMID: 15863846
Mock DM, Mock NI, Nelson RP, Lombard KA
J Pediatr Gastroenterol Nutr 1998 Mar;26(3):245-50. doi: 10.1097/00005176-199803000-00002. PMID: 9523856
Bartlett K, Ng H, Leonard JV
Clin Chim Acta 1980 Jan 15;100(2):183-6. doi: 10.1016/0009-8981(80)90081-9. PMID: 6766095
Lehnert W, Niederhoff H, Junker A, Saule H, Frasch W
Eur J Pediatr 1979 Oct;132(2):107-14. doi: 10.1007/BF00447377. PMID: 499258

Prognosis

Friebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P, Heubner G, Baumgartner MR, Hoffmann GF
Neuropediatrics 2006 Apr;37(2):72-8. doi: 10.1055/s-2006-924024. PMID: 16773504
Illsinger S, Lücke T, Zschocke J, Gibson KM, Das AM
Pediatr Neurol 2004 Mar;30(3):213-5. doi: 10.1016/j.pediatrneurol.2003.09.016. PMID: 15033206

Clinical prediction guides

Roland D, Jissendi-Tchofo P, Briand G, Vamecq J, Fontaine M, Ultré V, Acquaviva-Bourdain C, Mention K, Dobbelaere D
Mol Genet Metab 2017 Jun;121(2):111-118. Epub 2017 Mar 30 doi: 10.1016/j.ymgme.2017.03.006. PMID: 28396157
Ribeiro CA, Hickmann FH, Wajner M
Int J Dev Neurosci 2011 Feb;29(1):1-7. Epub 2010 Nov 2 doi: 10.1016/j.ijdevneu.2010.10.007. PMID: 21050883
Engelke UF, Kremer B, Kluijtmans LA, van der Graaf M, Morava E, Loupatty FJ, Wanders RJ, Moskau D, Loss S, van den Bergh E, Wevers RA
NMR Biomed 2006 Apr;19(2):271-8. doi: 10.1002/nbm.1018. PMID: 16541463

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...